Those who relapsed to opioid use, as defined by pre-specified criteria, were invited to enter Phase 2; Phase 2 consisted of 12 weeks of bup/nx stabilization treatment, followed by a 4-week taper and 8 weeks of post-treatment follow-up.
In one small study, the extent to which women discounted the future for themselves predicted quitting during pregnancy, with women who sustained a quit attempt beyond pregnancy discounting the future less than those who relapsed to smoking [ 15].
In the study on heroin population [ 26], the number of times of relapse to heroin was positively related to nicotine dependence and those having relapsed to heroin 3 or more times had higher possibility to report severe nicotine dependence (OR = 1.89).
Additionally we shall examine recurrence of suicidality specifically for those participants who relapse to Major Depression (MDD) and had a history of suicidal ideation or behaviour at entry to the trial.
Initially we shall examine recurrence of suicidality specifically for those participants who relapse to Major Depression and had a history of suicidal ideation or behaviour at entry to the trial.
A panel of 69 genes was identified as significantly differentially expressed between patients who relapsed to bone versus those who relapsed elsewhere.
Patients who relapsed to the viscera showed worse rate of response (OR, 0.44) compared with those who relapsed to the bone (OR, 0.69) or to soft tissues (OR, 1).
At present, current practice is to rechallenge patients relapsing more than 6 12 months after first-line chemotherapy with platinum-based regimens and to consider those relapsing sooner or who have truly refractory disease for newer agents, preferably within a clinical trial.
The intention of this approach is to reserve active treatment to those patients relapsing after primary orchidectomy and to spare the majority of patients any potentially toxic adjuvant treatment.
In their study, Palmi et al. [ 10] aimed at defining a cut-point for the CRLF2, as measured at diagnosis, that would allow to identify those children more likely to relapse in order to be able to tailor upfront the treatment intensity in future protocols.
